Home>
US Stocks>
Eli Lilly And Company

Eli Lilly And Company share price today

(LLY)

Eli Lilly And Company share price is $767.76 & ₹65,241.17 as on 21 Dec 2024, 2.30 'hrs' IST

$767.76

▲

10.22

(1.35%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Eli Lilly And Company share price in Dollar and Rupees. Guide to invest in Eli Lilly And Company from India. Also see the sentimental analysis on Indian investors investing in Eli Lilly And Company. Get details on the Indian mutual funds that are investing in Eli Lilly And Company. Get Analyst recommendations and forecasts along with all the Eli Lilly And Company's financials.

Eli Lilly And Company share price movements

Today's Low: $767.06
Today's High: $808.41
$767.76
0.09%
Downside
Day's Volatility :5.12%
Upside
5.03%
52 Weeks Low: $567.42
52 Weeks High: $972.53
$767.76
26.09%
Downside
52 Weeks Volatility :41.66%
Upside
21.06%

Eli Lilly And Company Returns

Period	Eli Lilly And Company	Sector (Health Care)	S&P500
3 Months	-16.41%	-11.1%	4.0%
6 Months	-13.75%	-6.0%	8.5%
1 Year	34.6%	2.7%	24.9%
3 Years	188.09%	0.6%	27.6%

Eli Lilly And Company Key Statistics

in dollars & INR

Previous Close	$757.54
Open	$811.35
Today's High	$808.41
Today's Low	$767.055
Market Capitalization	$681.3B
Today's Volume	$9.1M
52 Week High	$972.53
52 Week Low	$567.42
Revenue TTM	$40.9B
EBITDA	$16.6B
Earnings Per Share (EPS)	$9.25
PE Ratio	81.9
Dividend Yield	0.78%
Profit Margin	20.48%
Quarterly Earnings Growth YOY	0.68%
Return On Equity TTM	65.32%

How to invest in Eli Lilly And Company from India?

It is very easy for Indian residents to invest directly in Eli Lilly And Company from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eli Lilly And Company stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eli Lilly And Company or LLY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eli Lilly And Company or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eli Lilly And Company shares which would translate to 0.001 fractional shares of Eli Lilly And Company as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Eli Lilly And Company, in just a few clicks!

Returns in Eli Lilly And Company for Indian investors in Rupees

Investment Value

₹1,00,000

Eli Lilly And Company investment value today

Current value as on today

₹1,36,799

Returns

₹36,799

(+36.8%)

Returns from Eli Lilly And Company Stock

₹34,603 (+34.6%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Eli Lilly And Company

-35.32%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Eli Lilly And Company from India has reduced in the last 30 days as on Dec 21, 2024. -35.32% less purchase transactions for Eli Lilly And Company in the last 30 days versus the previous period.

12%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Eli Lilly And Company on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 12% more investors are searching Eli Lilly And Company in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Eli Lilly And Company

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	6779	-903.37	1.21%
Axis Innovation Fund Direct Growth	978	-24.88	0.53%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	1142	0.00	5.09%
Axis Growth Opportunities Fund Direct Growth	9329	-41.05	0.47%

Global Institutional Holdings in Eli Lilly And Company

Lilly Endowment Inc
10.77%
Vanguard Group Inc
8.20%
BlackRock Inc
7.32%
PNC Financial Services Group Inc
5.71%
State Street Corp
3.76%
FMR Inc
3.67%

Analyst Recommendation on Eli Lilly And Company

Buy

75%Buy

25%Hold

0%Sell

Based on 32 Wall street analysts offering stock ratings for Eli Lilly And Company(by analysts ranked 0 to 5 stars)

Based on 32 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Eli Lilly And Company

What analysts predicted

Upside of 28.17%

Current:

$767.76

Target:

$984.05

Insights on Eli Lilly And Company

Price Movement
In the last 3 years, LLY stock has moved up by 189.9%
Increasing Revenue
Eli Lilly And Company has shown strong revenue growth over the last three quarters. Revenue increased from $8.76 billion to $11.43 billion, with an average growth of 11.8% each quarter.
Decreasing Net Profit
Eli Lilly And Company has experienced a decline in its net profit over the last two quarters. The profit decreased from $2.96 billion to $970.3 million, which represents an average decline of 67.3% per quarter.

Eli Lilly And Company Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$21.5B	↓ 6.03%
Net Income	$3.2B	↓ 1683.54%
Net Profit Margin	15.04%	↑ 15.93%

	FY19	Y/Y Change
Revenue	$22.3B	↑ 3.84%
Net Income	$4.6B	↑ 43.5%
Net Profit Margin	20.78%	↑ 5.74%

	FY20	Y/Y Change
Revenue	$24.5B	↑ 9.95%
Net Income	$6.2B	↑ 33.55%
Net Profit Margin	25.24%	↑ 4.46%

	FY21	Y/Y Change
Revenue	$28.3B	↑ 15.4%
Net Income	$5.6B	↓ 9.88%
Net Profit Margin	19.71%	↓ 5.53%

	FY22	Y/Y Change
Revenue	$28.5B	↑ 0.79%
Net Income	$6.2B	↑ 11.88%
Net Profit Margin	21.88%	↑ 2.17%

	FY23	Y/Y Change
Revenue	$34.1B	↑ 19.56%
Net Income	$5.2B	↓ 16.08%
Net Profit Margin	15.36%	↓ 6.52%

	Q2 FY23	Q/Q Change
Revenue	$8.3B	↑ 19.43%
Net Income	$1.8B	↑ 31.1%
Net Profit Margin	21.21%	↑ 1.89%

	Q3 FY23	Q/Q Change
Revenue	$9.5B	↑ 14.27%
Net Income	$-57.4M	↓ 103.26%
Net Profit Margin	-0.6%	↓ 21.81%

	Q4 FY23	Q/Q Change
Revenue	$9.4B	↓ 1.53%
Net Income	$2.2B	↓ 3914.81%
Net Profit Margin	23.41%	↑ 24.01%

	Q1 FY24	Q/Q Change
Revenue	$8.8B	↓ 6.26%
Net Income	$2.2B	↑ 2.43%
Net Profit Margin	25.58%	↑ 2.17%

	Q2 FY24	Q/Q Change
Revenue	$11.3B	↑ 28.91%
Net Income	$3.0B	↑ 32.28%
Net Profit Margin	26.25%	↑ 0.67%

	Q3 FY24	Q/Q Change
Revenue	$11.4B	↑ 1.21%
Net Income	$970.3M	↓ 67.3%
Net Profit Margin	8.48%	↓ 17.77%

	FY18	Y/Y Change
Profit	$16.8B	↑ 0.06%

	FY19	Y/Y Change
Profit	$17.6B	↑ 4.68%

	FY20	Y/Y Change
Profit	$19.1B	↑ 8.29%

	FY21	Y/Y Change
Profit	$21.0B	↑ 10.23%

	FY22	Y/Y Change
Profit	$21.9B	↑ 4.31%

	FY23	Y/Y Change
Profit	$27.0B	↑ 23.41%

	Q2 FY23	Q/Q Change
Profit	$6.5B	↑ 21.96%

	Q3 FY23	Q/Q Change
Profit	$7.6B	↑ 17.43%

	Q4 FY23	Q/Q Change
Profit	$7.7B	↑ 0.73%

	Q1 FY24	Q/Q Change
Profit	$7.2B	↓ 5.99%

	Q2 FY24	Q/Q Change
Profit	$9.1B	↑ 26.25%

	Q3 FY24	Q/Q Change
Profit	$9.3B	↑ 1.49%

	FY18	Y/Y Change
Operating Cash Flow	$5.5B	↓ 1.62%
Investing Cash Flow	$1.9B	↓ 150.38%
Financing Cash Flow	$-5.9B	↓ 4240.88%

	FY19	Y/Y Change
Operating Cash Flow	$4.8B	↓ 12.45%
Investing Cash Flow	$-8.1B	↓ 524.08%
Financing Cash Flow	$-2.3B	↓ 60.63%

	FY20	Y/Y Change
Operating Cash Flow	$6.5B	↑ 34.38%
Investing Cash Flow	$-2.3B	↓ 72.05%
Financing Cash Flow	$-3.1B	↑ 34.96%

	FY21	Y/Y Change
Operating Cash Flow	$7.3B	↑ 11.71%
Investing Cash Flow	$-2.9B	↑ 26.94%
Financing Cash Flow	$-4.1B	↑ 31.69%

	FY22	Y/Y Change
Operating Cash Flow	$7.1B	↓ 2.43%
Investing Cash Flow	$-3.8B	↑ 31.23%
Financing Cash Flow	$-5.4B	↑ 30.87%

	FY23	Y/Y Change
Operating Cash Flow	$4.2B	↓ 40.15%
Investing Cash Flow	$-7.2B	↑ 90.08%
Financing Cash Flow	$3.5B	↓ 164.65%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$631.9M	↓ 63.49%
Investing Cash Flow	$-459.1M	↓ 33.35%
Financing Cash Flow	$-1.0B	↓ 350.64%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$2.2B	↑ 246.49%
Investing Cash Flow	$-3.1B	↑ 570.99%
Financing Cash Flow	$572.0M	↓ 155.35%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$-311.9M	↓ 114.25%
Investing Cash Flow	$-2.9B	↓ 5.07%
Financing Cash Flow	$3.5B	↑ 519.7%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$1.2B	↓ 473.84%
Investing Cash Flow	$-1.2B	↓ 59.73%
Financing Cash Flow	$-311.3M	↓ 108.78%

Eli Lilly And Company Technicals Summary

Sell

Neutral

Buy

Eli Lilly And Company is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Eli Lilly And Company Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Eli Lilly And Company	2.38%	-13.75%	34.6%	188.09%	485.41%
Johnson & Johnson	-7.09%	-3.12%	-7.07%	-13.97%	-1.35%
Pfizer Inc.	4.89%	-7.05%	-7.18%	-55.73%	-32.96%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Eli Lilly And Company	81.9	81.9	0.71	13.15	0.65	0.14	0.01	15.83
Johnson & Johnson	23.73	23.73	0.86	9.96	0.21	0.08	0.03	29.14
Pfizer Inc.	34.36	34.36	0.18	2.93	0.05	0.03	0.07	16.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Eli Lilly And Company	Buy	$681.3B	485.41%	81.9	20.48%
Johnson & Johnson	Buy	$345.7B	-1.35%	23.73	16.74%
Pfizer Inc.	Hold	$146.0B	-32.96%	34.36	7.16%

Eli Lilly And Company Dividend announcements

Eli Lilly And Company Dividends March, 2025
In the quarter ending March,2025. Eli Lilly And Company has declared dividend of $1.50
Read More

About Eli Lilly And Company

Lilly (Eli) & Co. is an American-based multinational pharma company with offices in 18 countries. Its headquarters are situated in Indianapolis, Indiana, and it sells drugs in over 125 countries. Colonel Eli Lilly was a pharmaceutical chemist and American Civil War veteran who founded this company in 1876. It is traded as LLY in the New York Stock Exchange (NYSE). Lilly employs over 33,000 people and generated a revenue of over 22 billion USD as of 2019. The company is committed to researching and developing high-quality drugs for humankind's welfare by remaining true to its work. In 1876, this company produced the medicinal drug called quinine used in the treatment of Malaria. Among its many commendable innovations were gelatin-coating for the capsules & pills and sugar-coated pills that make them easier to swallow. It also developed various drugs for treating syphilis, rheumatism, eczema, and psoriasis in the early 1880s. A scientific journal asserted that the Lilly operation was the largest capsule factory in the world in 1917. In 1923, Lilly mass-produced the Insulin under the name “Iletin” used to treat diabetes in the US. Moreover, it also became the company to mass-produce Penicillin in the 1940s and started producing the Polio vaccine in the early 1950s. It acquired CoLucid in 20017 for 960mn USD and Armo Biosciences for 1.6bn USD in 2018. Also, it purchased the Aurora Kinase A, an inhibitor developer, for 575mn USD. It acquired multiple companies for developing and researching breakthroughs. The company aims to bring life-changing research to the community while performing voluntary & philanthropist operations worldwide. Currently Eli Lilly And Company has a market cap of $893.59 Billion. It has a P.E ratio of 121.71. The shares of Eli Lilly And Company are trading at $767.76. .

Organization	Eli Lilly And Company
Employees	43000
CEO	Mr. David A. Ricks
Industry	Health Technology

Management People of Eli Lilly And Company

Name	Title
Mr. David A. Ricks	Chairman, CEO & President
Dr. Daniel M. Skovronsky M.D., Ph.D.	EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology
Ms. Anat Hakim J.D.	Executive VP, General Counsel & Secretary
Mr. Jacob S. Van Naarden	Executive VP & President of Loxo
Mr. Lucas E. Montarce	Executive VP & CFO
Mr. Donald A. Zakrowski	Senior VP of Finance & Chief Accounting Officer
Mr. Diogo Rau	EVP & Chief Information and Digital Officer
Mr. Alonzo Weems	EVP of Enterprise Risk Management and Chief Ethics & Compliance Officer
Mr. Eric Dozier	Executive Vice President of Human Resources & Diversity
Mr. Jeffrey N. Simmons	Senior VP & President of Elanco Animal Health

Important FAQs about investing in Eli Lilly And Company from India :

What is Eli Lilly And Company share price today?

Eli Lilly And Company share price today stands at $767.76, Open: $811.35 ; Previous Close: $757.54 ; High: $808.41 ; Low: $767.06 ; 52 Week High: $972.53 ; 52 Week Low: $567.42. The stock opens at $811.35, after a previous close of $757.54. The stock reached a daily high of $808.41 and a low of $767.06, with a 52-week high of $972.53 and a 52-week low of $567.42.

Can Indians buy Eli Lilly And Company shares?

Yes, Indians can invest in the Eli Lilly And Company (LLY) from India.

With INDmoney, you can buy Eli Lilly And Company at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Eli Lilly And Company at zero transaction cost.

How can I buy Eli Lilly And Company shares from India?

It is very easy to buy Eli Lilly And Company from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eli Lilly And Company be purchased?

Yes, you can buy fractional shares of Eli Lilly And Company with INDmoney app.

What are the documents required to start investing in Eli Lilly And Company stocks?

To start investing in Eli Lilly And Company, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.